Search
SOLACI Congress
HomeFileCoronary disease

Coronary disease

View Category

Acute coronary syndromes

5 Years of FAST-MI: If Unable to Meet the Timeline, Thrombolization Is the Way to Go

A large proportion of patients undergo primary angioplasty beyond the timelines recommended by clinical practice guidelines. These...
solaci -
Learn More
Coronary disease

Cath Lab Management Protocol for the COVID-19 Outbreak

The Interventional Cardiology Association and the Cardiac Beat Association from the Spanish Society of Cardiology have released...
solaci -
Learn More
Acute coronary syndromes

Impella and Adverse Events

Long after AHA 2019 had presented observational studies showing adverse events associated to Impella, JAMA is finally...
solaci -
Learn More
Coronary disease

ACC Recommendations against the New Coronavirus

The American College of Cardiology (ACC) has launched a document summarizing the potential implications of the new...
solaci -
Learn More
Acute coronary syndromes

TAVR: Should Transradial Approach be the Second Access Site?

Courtesy of Dr. Carlos Fava. One of the major challenges we interventional cardiologists still face is access management....
solaci -
Learn More
Chronic Ischemic cardiopathy

Chronic Coronary Syndromes Nowadays

Multiple drugs and treatment strategies have emerged in recent years to change significantly the prognosis of patients...
solaci -
Learn More
Coronary disease

Onyx ONE: More Options for Patients at High Risk for Bleeding

Since November 2015, when the LEADERS FREE was published in NEJM, polymer-free drug coated stents had undoubtedly...
solaci -
Learn More
Coronary disease

Repeat Revascularization Is Not Benign, at Least in Left Main Disease

After the “EXCEL scandal” at the end of last year, study investigators have been publishing explanations and...
solaci -
Learn More

SOLACI is the reference organization for Latin American cardiovascular interventionism.

Last News

Dynamic Coronary Roadmap: does it really help reduce contrast use?

Dr. Juan Manuel Pérez - 0
Contrast-induced nephropathy remains a relevant complication of percutaneous coronary interventions (PCI), particularly in patients with multiple comorbidities and complex coronary anatomies. Dynamic Coronary Roadmap...

Endoleaks after endovascular repair of complex aortic aneurysms: always reintervene or monitor with CTA?

Dr. Juan Manuel Pérez - 0
Endovascular repair of thoracoabdominal aneurysms requiring sealing above the renal arteries, with preservation of visceral vessels using fenestrated and/or branched devices (F/B-EVAR), has become...

Is it safe to use negative chronotropic drugs early after TAVI?

Dr. Juan Manuel Pérez - 0
TAVI is associated with a relevant incidence of conduction system disturbances and the development of atrioventricular block that may require permanent pacemaker implantation. Many...

Institutional News

SOLACI Wishes You Happy Holidays

solaci - 0
From the heart, Happy Holidays! The Latin American Society of Interventional Cardiology wishes all its members and the medical community across the continent a very Merry Christmas...

Condolences on the passing of Cristiam Arancibia

solaci - 0
The Latin American Society of Interventional Cardiology deeply mourns the passing of Lic. Cristiam Arancibia, first Director of the Chapter of Technicians and Nurses,...

Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

solaci - 0
Our webinar “Pulmonary Embolism in 2025: Risk Stratification and Novel Therapeutic Approaches” is now available to watch. The session took place on November 25,...

Access

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Terms of Use -Privacy Policy